Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor

BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same

Fused heterotricyclic organic coumpounds, pharmaceutical compositions, and medical uses thereof

Sublingual films

Antidiabetic compounds

Fused imidazole compounds

Heterocyclic compounds useful as PDK1 inhibitors

PHARMACEUTICAL FORMULATION FOR REDUCING FREQUENCY OF URINATION AND METHOD OF USE THEREOF

Compounds and methods for kinase modulation, and indications therefor

Substituted pyrido[3,4-b]pyrazines as Syk inhibitors

Parenteral formulations of dopamine agonists

Particulate materials

FILM DOSAGE FORMS CONTAINING AMORPHOUS ACTIVE AGENTS

Apoptosis signal-regulating kinase inhibitors

Substituted pyrrolo[2,3-b]pyridines as MLK inhibitors

Double-layer tablet and preparation method thereof

Substituted tetrazolo[1,5-a]pyrazines as ROR-gamma inhibitors

Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases

Method for the treatment of residual symptoms of schizophrenia

Substituted imidazo[1,2-a]pyrazines as Syk inhibitors

-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders

Inhibitors of the renal outer medullary potassim channel

Quinoline derivatives as PDE10A enzyme inhibitors

E-PROSTANOID RECEPTOR, PTGER3, AS A NOVEL ANTI-DIABETIC THERAPEUTIC TARGET

Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same

Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors

Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug

Pharmacologically active compounds

IMIDAZOPYRIDINE, IMIDAZOPYRIMIDINE AND IMIDAZOPYRAZINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS

Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

ORAL DISPERSIBLE COMPOSITION OF A DPP-IV INHIBITOR

REGIMEN AND METHOD FOR TREATMENT OF TYPE 2 DIABETES

Protein kinase inhibitors

Substituted pyridine and pyrazine BMI-1 inhibitors

COMPOSITION FOR REDUCING FREQUENCY OF URINATION, METHOD OF MAKING AND USE THEREOF

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

ORALLY DISINTEGRATING POROUS FILM COMPRISING PHARMACOLOGICAL ACTIVE INGREDIENT AND METHOD FOR PREPARING SAME

SUBSTITUTED DIHYDROPYRIDO[3,4-B]PYRAZINONES AS DUAL INHIBITORS OF BET PROTEINS AND POLO-LIKE KINASES

Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders

Tetracyclic autotaxin inhibitors

Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors

Platform drug delivery system utilizing crystal engineering and theanine dissolution

Platform drug delivery system utilizing crystal engineering and theanine dissolution

Platform drug delivery system utilizing crystal engineering and theanine dissolution

Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof

Treatment of erectile dysfunction and other indications

Treatment of erectile dysfunction and other indications

Inhibitors of phosphodiesterase type 5A for reducing skeletal muscle fatigue, edema, and damage in a patient having muscle fatigue due to increased age or exercise

COMPOSITE FORMULATION COMPRISING TADALAFIL AND AMLODIPINE

Heterocyclic compounds

BENZOPIPERAZINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS

Kappa opioid receptor effectors and uses thereof

ORAL LIQUID PHARMACEUTICAL COMPOSITION OF A DPP-IV INHIBITOR

BENZOPIPERAZINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS

TREATMENT OF ERECTILE DYSFUNCTION AND OTHER INDICATIONS

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one

Combined application of isothiocyanate compound and anti-cancer medicine

Compounds suitable for the treatment of myeloproliferative neoplasms as well as methods for the diagnosis/prognosis of myeloproliferative neoplasms

POLYCYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

Method Of Making Particles For Use In A Pharmaceutical Composition

FILM DOSAGE FORMS CONTAINING AMORPHOUS ACTIVE AGENTS

Piperazinyl derivatives for the treatment of cancer

Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects

Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof

Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors

Therapeutically active compositions and their methods of use

INTRANASAL DHE FOR THE TREATMENT OF HEADACHE

Heteroaryl pyridone and aza-pyrodine compounds

Chemokine receptor binding heterocyclic compounds with enhanced efficacy

Method of treating glioma

NOVEL TRICYCLIC COMPOUNDS

Bile acid recycling inhibitors for treatment of obesity and diabetes

Parasiticidal compositions comprising multiple active agents, methods and uses thereof

Substituted quinoxalines as FGFR kinase inhibitors

Low-Sodium Effervescent Pharmaceutical Formulations

GLP-1 receptor modulators

Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Inhibitor of breast cancer resistance protein (BCRP)

Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction

Compounds

Compositions and methods for treating mitochondrial diseases

NOVEL NEUROKININ 1 RECEPTOR ANTAGONIST COMPOUNDS II

NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER

Method for treating erectile dysfunction

SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION

Enzymatic Route For The Preparation Of Chiral Gamma-Aryl-Beta-Aminobutyric Acid Derivatives

Optically pure benzyl-4-chlorophenyl-C-glucoside derivative

ANTI-DIABETIC COMPOSITION

Method of increasing the bioavailability of an HIV drug

Compounds as HIF-1α inhibitors and manufacturing process thereof

BET-PROTEIN-INHIBITING DIHYDROPYRIDOPYRAZINONES

Therapeutic approaches for treating Parkinson's disease

Substituted pyrazolo[1,5-A]-pyridine-3-carboxamides and use thereof

Substituted bicyclic compounds as bromodomain inhibitors

Extruded chewable formulation comprising bound water

SUBSTITUTED IMIDAZO[1,2-A]PYRAZINECARBOXAMIDES AND USE THEREOF

TGFβR antagonists

Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

MODIFIED BET-PROTEIN-INHIBITING DIHYDROQUINOXALINONES AND DIHYDROPYRIDOPYRAZINONES

Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them

Pharmaceutical formulation for bedwetting and method of use thereof

N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS

Combination methods for treating cancers

4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as BtK inhibitors

Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use

Compositions and methods for efficacious and safe delivery of siRNA using specific chitosan-based nanocomplexes

Cooperative Medication Combination Systems

4-imidazopyridazin-1-yl-benzamides as Btk inhibitors

Sublingual films

Assays for screening for or identifying an agent or molecule that can block or inhibit AVB3 integrin from forming a complex with KRAS

Substituted bicyclic compounds as bromodomain inhibitors

Combination therapy using dual inhibitor of c-MET and EGFR and IGF-1R inhibitor

Combination therapy using c-Met inhibitor and IGF-1R inhibitor for c-Met inhibitor resistant cancers

Substituted benzoxazoles

4-amino-6-phenyl-6,7-dihydro[1,2,3]triazolo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE)

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

Substituted [1,2,4]triazolo[4,3-a]pyrazines as BRD4 inhibitors

Azetidinyloxyphenylpyrrolidine compounds

Orally disintegrating tablet formulation for enhanced bioavailability

4-amino-6-phenyl-5,6-dihydroimidazo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE)

Fused tricyclic heterocyclic compounds as HIV integrase inhibitors

Compounds and compositions for the treatment of parasitic disease

Imidazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug

Pharmaceutical formulations for treating ocular conditions

Dry eye treatments

Methods of increasing tear production

TOPOISOMERASE II POISONS AND METHODS OF MAKING AND USING SAME

Abuse Deterrent Immediate Release Formulation

Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

Methods of improving ocular discomfort

Substituted pyrazolo[1,5-a]pyridines as PDE-10 inhibitors

Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors

Compounds and methods for inhibiting histone demethylases

METHOD FOR THE PRODUCTION OF A MEDICAMENT CONTAINING TADALAFIL

Combination of Kinase Inhibitors and Uses Thereof

Deuterated pyrazino[2,1-a]isoquinoline compounds and methods of treatment using the same

6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

Bicyclic heterocycle compounds and their uses in therapy

Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists

Ophthalmic device having therapeutic agent delivery capability and method of forming same

Heterocyclic compounds and uses thereof

COMPOSITION FOR REDUCING FREQUENCY OF URINATION, METHOD OF MAKING AND USE THEREOF

TADALAFIL FREE BASE-CONTAINING FILM DOSAGE FORM CONTAINING POLYETHYLENE GLYCOL-BASED POLYMER AND/OR VINYL PYRROLIDONE-BASED POLYMER AS DISPERSION STABILIZER

Synergistic compositions

TRANSDERMAL DELIVERY OF SILDENAFIL AND OTHER PHOSPHODIESTERASE TYPE 5 INHIBITORS

USE OF PHOSPHODIESTERASE 5A INHIBITORS FOR THE TREATMENT OF MUSCULAR DYSTROPHY

PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS

Compositions and methods for the reduction or prevention of hepatic steatosis

Substituted pyrido[1,2-a]pyrazines as HIV integrase inhibitors

Syk inhibitors

Substituted imidazo[1,2-d]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections

Substituted 7-azabicycles and their use as orexin receptor modulators

Compositions and methods of using the compositions for plaque softening

N-(IMIDAZOLIDIN-2-YLIDENE)QUINOLINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS

Substituted 1,5-naphthyridines as endonuclease inhibitors

APPLICATION OF 5-HT6 RECEPTOR ANTAGONISTS FOR THE ALLEVIATION OF COGNITIVE DEFICITS OF DOWN SYNDROME

Bromocriptine formulations

ANTIVIRAL INDOLO[2,3-B]QUINOXALINE

Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity

NAMPT and ROCK inhibitors

PYRIDO [4,3-B]INDOLE AND PYRIDO [3,4-B] INDOLE DERIVATIVES AND METHODS OF USE

Methods and compositions for sleep disorders and other disorders

METHODS FOR MODULATING DISSOLUTION, BIOAVAILABILITY, BIOEQUIVALENCE AND DRUG DELIVERY PROFILE OF THIN FILM DRUG DELIVERY SYSTEMS, CONTROLLED-RELEASE THIN FILM DOSAGE FORMATS, AND METHODS FOR THEIR MANUFACTURE AND USE

Process for preparing chiral dipeptidyl peptidase-IV inhibitors

MLK INHIBITORS AND METHODS OF USE

Benzamides

Substituted [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators

Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction

USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS

Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition

Tetrazole compounds as calcium channel blockers

Modulators of toll-like receptors for the treatment of HIV

TREATMENT OF CANCER WITH TOR KINASE INHIBITORS

Statins in the treatment of muscular dystrophies and myopathies

Inhibitors of the renal outer medullary potassium channel

Pyrido[2,3-b]pyrazin-8-substituted compounds and their use

Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease

PYRIDOPYRAZINE COMPOUNDS AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA

Indole derivatives useful as anti-diabetic agents

NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

Use of ITK inhibitors for the treatment of cancer

Compounds for treatment of cancer

Compounds for treatment of fibrosis diseases

Methods of inhibiting IGF-1R activation or downtream signalling thereof to reduce radiation-induced cellular senescence

Pharmaceutical compositions comprising Tadalafil

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof.

Fluoroergoline analogs

CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR

Treatment of neurological disorders

Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof

Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for tor kinase inhibitory activity

Method for treating cancer using a combination of Chk1 and ATR inhibitors

BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES

COMBINATION METHODS AND COMPOSITIONS INCLUDING SLEEP THERAPEUTICS FOR TREATING MOOD

Oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same

Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors

BTK inhibitors

ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS

Use of NK-1 receptor antagonists for treating hypomagnesemia, neurogenic inflammation, and cardiac dysfunction associated with EGFR-blocking drugs

Use of levocetirizine and montelukast in the treatment of autoimmune disorders

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

A DOSAGE FORM FOR ADMINISTERING AN ACTIVE PRINCIPLE FOR ACCELERATED SLEEP INDUCTION AND/OR FOR TREATING SLEEP DISORDERS AND/OR FOR TREATING A CENTRAL NERVOUS SYSTEM DISORDER

Method of inhibiting ABCG2 and related treatments

Tablets with improved acceptance and good storage stability

Compositions and methods for stabilizing luminogenic substrates

Liver X receptor modulators

SMALL-MOLECULE BINDING SITE ON PRO-APOPTOTIC BAX REGULATES INHIBITION OF BAX ACTIVITY

Substituted (3S,11AR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11A-hexahydro[1,3]oxazolo[3,2-A]pyrido[1,2-D]pyrazine-8-carboxamides as HIV agents

USP14 inhibitors for treating or preventing viral infections

Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases

Method of treating metabolic disorders and depression with dopamine receptor agonists

Inhibitors of the renal outer medullary potassium channel

4-pyridinonetriazine derivatives as HIV integrase inhibitors

Methods and materials for treating calcific aortic valve stenosis

Substituted 7-azabicycles and their use as orexin receptor modulators

Substituted [1,2,4]triazolo[1,5-a]pyrazines as phosphodiesterase inhibitors

Compositions and methods for regulating glucose homeostasis and insulin action

Hepatitis C virus inhibitors

Substituted cyanoguanidines as oral anti-virals

Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it

Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor

Pharmaceutical formulation comprising 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H-indolo-(2,3-B)quinoxaline

EFFERVESCENT TABLET FORMULATIONS OF DAPOXETINE AND A PDE5 INHIBITOR

METHODS FOR TREATING PARKINSON'S DISEASE

Heteroaromatic compounds and their use as dopamine D1 ligands

Compounds useful for treating AIDS

Inhibitors of Bruton's tyrosine kinase

8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS

Solid forms comprising 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, and a coformer, compositions and methods of use thereof

Heteroaryl alkyne compound and use thereof

Compounds for treating cancer

Composition comprising phosphodiesterase type 5 inhibitor for inhibiting apoptosis of nerve cells

Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines

Rejuvenation of precursor cells

Heteroaryl compounds and methods of use thereof

Substituted pyrrolo[2,3-b]pyrazines as JAK3 inhibitors

Methods of treating muscular dystrophy

Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors

Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors

Substituted [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators

Method for improving the bioavailability of low aqueous solubility drugs

Process for the preparation of an intermediate for an orexin receptor antagonist

DETERMINATION OF SINGLE NUCLEOTIDE POLYMORPHISMS USEFUL TO PREDICT RESPONSE FOR RASAGILINE

Substituted 6-aza-isoindolin-1-one derivatives

AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE

Derivatives of azaindazole or diazaindazole type for treating a cancer overexpressing Trk

CYCLIC AMIDE DERIVATIVE

ORAL PREPARATION AND METHOD FOR PRODUCING THE SAME

Triazolopyrazine derivative and use thereof

CYCLIC GLYCYL-2-ALLYL PROLINE IMPROVES COGNITIVE PERFORMANCE IN IMPAIRED ANIMALS

Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors

CYSTATIN C AND GALECTIN-3 AS BIOMARKERS FOR PULMONARY ARTERIAL HYPERTENSION

Hematopoietic growth factor mimetic small molecule compounds and their uses

Tropomyosin-Related Kinase Inhibitors

METHODS FOR IMPROVING RESISTANCE TO SKELETAL MUSCLE FATIGUE

Liver X receptor modulators

INHIBITORS OF HEPATITIS C VIRUS REPLICATION

Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases

Medical use of a DPP-4 inhibitor

Pyrrole antifungal agents

NOVEL ERGOLINE DERIVATIVES AND USES THEREOF

Uses of orvepitant

Benzopiperazine compositions as BET bromodomain inhibitors

NOVEL EFFERVESCENT SACHET FORMULATIONS OF DAPOXETINE AND A PDE5 INHIBITOR

Substituted-1,4-dihydropyrazolo[4,3-b]indoles

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

2,3,5-trisubstituted thiophene compounds and uses thereof

Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathies

Method for treating a pulmonary hypertension condition

Benzimidazole hexahydrofuro[3,2-b]furan derivatives

Substituted pyrrolo[2,3-b]pyrazines as serine/threonine kinase inhibitors

Pyrrolo[2,3-B]pyrazines as SYK inhibitors

Benzimidazole tetrahydrofuran derivatives

Compositions for oral administration to animals, production methods thereof and uses of same

SUBSTITUTED BICYCLIC ALKOXY PYRAZOLE ANALOGS AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS

NOVEL ORALLY ADMINISTERED PHARMACEUTICAL FORMULATIONS

Agent for treating or inhibiting recurrence of acute myeloid leukemia

Neprilysin inhibitors

Azabenzimidazole tetrahydropyran derivatives

CELLULAR BLOOD MARKERS FOR EARLY DIAGNOSIS OF ALS AND FOR ALS PROGRESSION

Application of 5-HT6 receptor antagonists for the alleviation of cognitive deficits of down syndrome

Azabenzimidazole tetrahydrofuran derivatives

ORAL FILM FORMULATIONS COMPRISING DAPOXETINE AND TADALAFIL

Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug

Inhibitors of CRL4 ubiquitin ligase and uses thereof

Substituted imidazo[1,2-a]pyrazines as TNF activity modulators

Inhibitors of histone deacetylase

Method of making an anhydrous, fat soluble, chewable drug delivery formulation

Substituted imidazoles as PDE10A inhibitors

Derivatives of azaindazole or diazaindazole type for treating pain

Plant extracts made of and use thereof to boost cognitive performance

Pyrido[2,3-B]pyrazin-8-substituted compounds and their use

Crystalline forms of an antiviral compound

Heteroaryl compounds and uses thereof

Substituted quinolines as PDE-10 inhibitors

Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors